STOCK TITAN

Coatue Affiliates Report Material 9.9% Holding in Hinge Health (HNGE)

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G

Rhea-AI Filing Summary

Coatue and affiliated entities report a significant passive stake in Hinge Health's Class A stock. The filing discloses aggregate beneficial ownership of 2,960,200 shares by Coatue Management and Philippe Laffont, equal to 9.9% of the Class A shares. Two affiliated vehicles are separately disclosed: Coatue Growth Fund IV LP holds 2,401,696 shares (8.1%) and Coatue US 70 LLC holds 2,300,512 shares (7.9%). The reported shares include those directly held and those issuable upon conversion of Class B common stock, and all reported holdings are shown as shared voting and dispositive power with no sole voting or sole dispositive power.

Positive

  • Material stake disclosed: Coatue-related reporting persons hold 2,960,200 Class A shares representing 9.9% of the class.
  • Transparency on composition: Filing specifies that reported shares include those issuable upon conversion of Class B common stock.

Negative

  • No sole voting or dispositive power: All reported shares are shown with shared voting and shared dispositive power, indicating no unilateral control by a single reporting person.

Insights

Coatue's near-10% stake is material and could influence market perception but does not imply sole control.

The Schedule 13G shows Coatue-related entities and Philippe Laffont beneficially own 2.96 million Class A shares (9.9%). For investors, a sub-10% passive disclosure signals meaningful economic exposure without an expressed intent to exert control. The filing clarifies that ownership includes shares issuable upon conversion of Class B stock, which can affect dilution and voting calculations. Shared voting and dispositive power indicates coordination among affiliates rather than unilateral control, so corporate governance outcomes remain subject to broader shareholder composition.

Material ownership is disclosed but absence of sole voting power limits immediate governance impact.

The report documents shared voting and dispositive authority over the disclosed shares and explicitly shows zero sole voting or dispositive power across reporting persons. That structure suggests Coatue acts in concert across advisory clients and funds. While a nearly 10% economic stake is noteworthy, the lack of sole voting control means any board or strategic influence would likely require cooperation with other shareholders or formal engagement declared in future filings.






Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



Coatue Management, L.L.C.
Signature:/s/ Philippe Laffont
Name/Title:Philippe Laffont/Authorized Signatory
Date:08/14/2025
Philippe Laffont
Signature:/s/ Philippe Laffont
Name/Title:Philippe Laffont
Date:08/14/2025
Coatue Growth Fund IV LP
Signature:By: Coatue Growth Fund IV GP LLC, it general partner, By: /s/ Philippe Laffont
Name/Title:Philippe Laffont/Authorized Signatory
Date:08/14/2025
Coatue US 70 LLC
Signature:By: Coatue Management, L.L.C., its investment manager, By: /s/ Philippe Laffont
Name/Title:Philippe Laffont/Authorized Signatory
Date:08/14/2025

Comments accompanying signature: * Each Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his, her or its pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. To the extent that "ownership of 5 percent or less of a class" was indicated in Item 5, such response only applies to the Reporting Person(s) that indicated elsewhere herein that it beneficially owns five percent (5%) or less of the class.
Exhibit Information

Exhibit A - Joint Filing Agreement Exhibit B - Control Person Identification

FAQ

What stake in Hinge Health (HNGE) does Coatue report?

Coatue Management and affiliated reporting persons disclose ownership of 2,960,200 Class A shares, representing 9.9% of the Class A stock.

How many shares does Coatue Growth Fund IV LP hold in Hinge Health (HNGE)?

Coatue Growth Fund IV LP is reported to beneficially own 2,401,696 shares, equal to 8.1% of the Class A shares.

Does any reporting person have sole voting control over the Hinge Health shares?

No. The filing states 0 sole voting power and lists all reported holdings under shared voting and shared dispositive power.

Are the reported shares only directly held Class A shares?

No. The filing notes the reported number includes shares directly held and shares issuable upon conversion of Class B common stock.

Which Coatue entities are named in the Schedule 13G for Hinge Health (HNGE)?

The filing names Coatue Management, L.L.C., Philippe Laffont, Coatue Growth Fund IV LP, and Coatue US 70 LLC as reporting persons.
Hinge Health, Inc.

NYSE:HNGE

HNGE Rankings

HNGE Latest News

HNGE Latest SEC Filings

HNGE Stock Data

3.79B
34.49M
8.08%
132.02%
1.61%
Health Information Services
Services-computer Processing & Data Preparation
Link
United States
SAN FRANCISCO